Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

NUTX vs CYH vs THC vs HCA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NUTX
Nutex Health, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$801M
5Y Perf.-90.3%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$408M
5Y Perf.-63.6%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+162.6%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+102.8%

NUTX vs CYH vs THC vs HCA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NUTX logoNUTX
CYH logoCYH
THC logoTHC
HCA logoHCA
IndustryMedical - Healthcare Information ServicesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$801M$408M$17.01B$95.95B
Revenue (TTM)$880M$21.48B$21.45B$75.60B
Net Income (TTM)$96M$-88M$1.70B$6.78B
Gross Margin47.5%53.7%42.8%41.5%
Operating Margin31.4%-39.8%16.1%15.8%
Forward P/E6.5x0.8x10.7x14.4x
Total Debt$351M$11.58B$13.17B$50.20B
Cash & Equiv.$186M$260M$2.88B$1.04B

NUTX vs CYH vs THC vs HCALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NUTX
CYH
THC
HCA
StockApr 22May 26Return
Nutex Health, Inc. (NUTX)1009.7-90.3%
Community Health Sy… (CYH)10036.4-63.6%
Tenet Healthcare Co… (THC)100262.6+162.6%
HCA Healthcare, Inc. (HCA)100202.8+102.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: NUTX vs CYH vs THC vs HCA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 3 of 7 categories, making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. Nutex Health, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. CYH and THC also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
NUTX
Nutex Health, Inc.
The Growth Play

NUTX is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 82.4%, EPS growth 7.9%, 3Y rev CAGR 58.6%
  • 82.4% revenue growth vs CYH's -1.2%
  • 11.0% margin vs CYH's -0.4%
Best for: growth exposure
CYH
Community Health Systems, Inc.
The Value Play

CYH is the clearest fit if your priority is value.

  • Lower P/E (0.8x vs 14.4x)
Best for: value
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 5.2% 10Y total return vs HCA's 450.5%
  • Lower volatility, beta 0.71, current ratio 1.76x
  • PEG 0.32 vs HCA's 0.68
  • Beta 0.71, current ratio 1.76x
Best for: long-term compounding and sleep-well-at-night
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Beta 0.29 vs NUTX's 2.01
  • 0.7% yield; 5-year raise streak; the other 3 pay no meaningful dividend
  • 11.3% ROA vs CYH's -0.7%, ROIC 19.9% vs -70.1%
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthNUTX logoNUTX82.4% revenue growth vs CYH's -1.2%
ValueCYH logoCYHLower P/E (0.8x vs 14.4x)
Quality / MarginsNUTX logoNUTX11.0% margin vs CYH's -0.4%
Stability / SafetyHCA logoHCABeta 0.29 vs NUTX's 2.01
DividendsHCA logoHCA0.7% yield; 5-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)THC logoTHC+27.4% vs CYH's -11.7%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CYH's -0.7%, ROIC 19.9% vs -70.1%

NUTX vs CYH vs THC vs HCA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NUTXNutex Health, Inc.
FY 2024
Hospital Division
100.0%$449M
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B

NUTX vs CYH vs THC vs HCA — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNUTXLAGGINGHCA

Income & Cash Flow (Last 12 Months)

NUTX leads this category, winning 4 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 85.9x NUTX's $880M. NUTX is the more profitable business, keeping 11.0% of every revenue dollar as net income compared to CYH's -0.4%.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
RevenueTrailing 12 months$880M$21.5B$21.5B$75.6B
EBITDAEarnings before interest/tax$297M-$7.8B$4.3B$15.5B
Net IncomeAfter-tax profit$96M-$88M$1.7B$6.8B
Free Cash FlowCash after capex$270M-$200M$3.3B$7.7B
Gross MarginGross profit ÷ Revenue+47.5%+53.7%+42.8%+41.5%
Operating MarginEBIT ÷ Revenue+31.4%-39.8%+16.1%+15.8%
Net MarginNet income ÷ Revenue+11.0%-0.4%+7.9%+9.0%
FCF MarginFCF ÷ Revenue+30.7%-0.9%+15.6%+10.2%
Rev. Growth (YoY)Latest quarter vs prior year+2.2%+2.8%+2.8%+6.7%
EPS Growth (YoY)Latest quarter vs prior year+154.7%-45.2%+87.6%+44.6%
NUTX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CYH leads this category, winning 3 of 7 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 95% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
Market CapShares × price$801M$408M$17.0B$95.9B
Enterprise ValueMkt cap + debt − cash$967M$11.7B$27.3B$145.1B
Trailing P/EPrice ÷ TTM EPS12.84x0.77x12.53x15.12x
Forward P/EPrice ÷ next-FY EPS est.6.50x10.65x14.40x
PEG RatioP/E ÷ EPS growth rate0.38x0.72x
EV / EBITDAEnterprise value multiple3.27x6.34x9.37x
Price / SalesMarket cap ÷ Revenue0.92x0.03x0.80x1.27x
Price / BookPrice ÷ Book value/share2.15x1.97x
Price / FCFMarket cap ÷ FCF3.26x1.96x6.72x12.47x
CYH leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

NUTX leads this category, winning 8 of 9 comparable metrics.

NUTX delivers a 22.2% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $20 for THC. NUTX carries lower financial leverage with a 0.83x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), NUTX scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
ROE (TTM)Return on equity+22.2%+19.6%
ROA (TTM)Return on assets+10.5%-0.7%+5.7%+11.3%
ROICReturn on invested capital+38.0%-70.1%+13.2%+19.9%
ROCEReturn on capital employed+43.2%-87.3%+13.8%+27.0%
Piotroski ScoreFundamental quality 0–97677
Debt / EquityFinancial leverage0.83x1.47x
Net DebtTotal debt minus cash$166M$11.3B$10.3B$49.2B
Cash & Equiv.Liquid assets$186M$260M$2.9B$1.0B
Total DebtShort + long-term debt$351M$11.6B$13.2B$50.2B
Interest CoverageEBIT ÷ Interest expense9.13x4.89x4.28x5.37x
NUTX leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $224 for NUTX. Over the past 12 months, THC leads with a +27.4% total return vs CYH's -11.7%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs CYH's -6.0% — a key indicator of consistent wealth creation.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
YTD ReturnYear-to-date-9.2%-6.6%-2.7%-8.6%
1-Year ReturnPast 12 months+14.6%-11.7%+27.4%+19.7%
3-Year ReturnCumulative with dividends+74.8%-16.8%+178.5%+57.4%
5-Year ReturnCumulative with dividends-97.8%-81.0%+190.4%+109.7%
10-Year ReturnCumulative with dividends-97.8%-80.3%+523.4%+450.5%
CAGR (3Y)Annualised 3-year return+20.5%-6.0%+40.7%+16.3%
THC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — THC and HCA each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than NUTX's 2.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 78.5% from its 52-week high vs CYH's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
Beta (5Y)Sensitivity to S&P 5002.10x1.57x0.74x0.31x
52-Week HighHighest price in past year$193.07$4.47$247.21$556.52
52-Week LowLowest price in past year$77.21$2.38$146.60$330.00
% of 52W HighCurrent price vs 52-week peak+69.7%+64.8%+78.5%+77.1%
RSI (14)Momentum oscillator 0–10059.746.452.930.8
Avg Volume (50D)Average daily shares traded197K1.6M1.2M1000K
Evenly matched — THC and HCA each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 1 of 1 comparable metric.

Analyst consensus: NUTX as "Buy", CYH as "Hold", THC as "Buy", HCA as "Buy". Consensus price targets imply 52.3% upside for NUTX (target: $205) vs 1.2% for CYH (target: $3). HCA is the only dividend payer here at 0.69% yield — a key consideration for income-focused portfolios.

MetricNUTX logoNUTXNutex Health, Inc.CYH logoCYHCommunity Health …THC logoTHCTenet Healthcare …HCA logoHCAHCA Healthcare, I…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuy
Price TargetConsensus 12-month target$205.00$2.93$259.50$527.45
# AnalystsCovering analysts2373246
Dividend YieldAnnual dividend ÷ price+0.7%
Dividend StreakConsecutive years of raises1205
Dividend / ShareAnnual DPS$2.94
Buyback YieldShare repurchases ÷ mkt cap+0.6%+0.5%+8.4%+10.5%
HCA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

NUTX leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 1 (Valuation Metrics). 1 tied.

Best OverallNutex Health, Inc. (NUTX)Leads 2 of 6 categories
Loading custom metrics...

NUTX vs CYH vs THC vs HCA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NUTX or CYH or THC or HCA a better buy right now?

For growth investors, Nutex Health, Inc.

(NUTX) is the stronger pick with 82. 4% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Nutex Health, Inc. (NUTX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NUTX or CYH or THC or HCA?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Nutex Health, Inc. is actually cheaper at 6. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 32x versus HCA Healthcare, Inc. 's 0. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — NUTX or CYH or THC or HCA?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -97. 8% for Nutex Health, Inc. (NUTX). Over 10 years, the gap is even starker: THC returned +511. 4% versus NUTX's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NUTX or CYH or THC or HCA?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 31β versus Nutex Health, Inc. 's 2. 10β — meaning NUTX is approximately 583% more volatile than HCA relative to the S&P 500. On balance sheet safety, Nutex Health, Inc. (NUTX) carries a lower debt/equity ratio of 83% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — NUTX or CYH or THC or HCA?

By revenue growth (latest reported year), Nutex Health, Inc.

(NUTX) is pulling ahead at 82. 4% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, NUTX leads at 58. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NUTX or CYH or THC or HCA?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUTX leads at 31. 5% versus -79. 4% for CYH. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NUTX or CYH or THC or HCA more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 32x versus HCA Healthcare, Inc. 's 0. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nutex Health, Inc. (NUTX) trades at 6. 5x forward P/E versus 14. 4x for HCA Healthcare, Inc. — 7. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUTX: 52. 3% to $205. 00.

08

Which pays a better dividend — NUTX or CYH or THC or HCA?

In this comparison, HCA (0.

7% yield) pays a dividend. NUTX, CYH, THC do not pay a meaningful dividend and should not be held primarily for income.

09

Is NUTX or CYH or THC or HCA better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 0. 7% yield, +457. 9% 10Y return). Nutex Health, Inc. (NUTX) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +457. 9%, NUTX: -97. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NUTX and CYH and THC and HCA?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NUTX is a small-cap high-growth stock; CYH is a small-cap deep-value stock; THC is a mid-cap deep-value stock; HCA is a mid-cap deep-value stock. HCA pays a dividend while NUTX, CYH, THC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NUTX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NUTX and CYH and THC and HCA on the metrics below

Revenue Growth>
%
(NUTX: 2.2% · CYH: 284.9%)
P/E Ratio<
x
(NUTX: 12.8x · CYH: 0.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.